ArticleInfection and drug resistance2021

Outcomes After Switching to BIC/FTC/TAF in Patients with Virological Failure to Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors: A Real-World Cohort Study.

Hui-Min Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.